Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome
- PMID: 20360470
- PMCID: PMC2892951
- DOI: 10.1182/blood-2010-01-263145
Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome
Abstract
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by childhood onset of lymphadenopathy, hepatosplenomegaly, autoimmune cytopenias, elevated numbers of double-negative T (DNT) cells, and increased risk of lymphoma. Most cases of ALPS are associated with germline mutations of the FAS gene (type Ia), whereas some cases have been noted to have a somatic mutation of FAS primarily in their DNT cells. We sought to determine the proportion of patients with somatic FAS mutations among a group of our ALPS patients with no detectable germline mutation and to further characterize them. We found more than one-third (12 of 31) of the patients tested had somatic FAS mutations, primarily involving the intracellular domain of FAS resulting in loss of normal FAS signaling. Similar to ALPS type Ia patients, the somatic ALPS patients had increased DNT cell numbers and elevated levels of serum vitamin B(12), interleukin-10, and sFAS-L. These data support testing for somatic FAS mutations in DNT cells from ALPS patients with no detectable germline mutation and a similar clinical and laboratory phenotype to that of ALPS type Ia. These findings also highlight the potential role for somatic mutations in the pathogenesis of nonmalignant and/or autoimmune hematologic conditions in adults and children.
Figures
Comment in
-
Somatic ALPS: a FAScinating condition.Blood. 2010 Jun 24;115(25):5125-6. doi: 10.1182/blood-2010-04-278465. Blood. 2010. PMID: 20576815 No abstract available.
-
Double-negative T cells are non-ALPS-specific markers of immune dysregulation found in patients with aplastic anemia.Blood. 2010 Dec 2;116(23):5072-3. doi: 10.1182/blood-2010-09-306910. Blood. 2010. PMID: 21127186 No abstract available.
References
-
- Sneller MC, Wang J, Dale JK, et al. Clinical, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Blood. 1997;89(4):1341–1348. - PubMed
-
- Avila NA, Dwyer AJ, Dale JK, et al. Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis—CT and US features. Radiology. 1999;212(1):257–263. - PubMed
-
- Lopatin U, Yao X, Williams RK, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood. 2001;97(10):3161–3170. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
